Daiichi’s EZH Contender Moves Ahead In Leukemia/Lymphoma

Pivotal Trial The First For A Dual Inhibitor

 
• By Ian Haydock
  
Leukemia
Novel Daiichi ATL Candidate Enters Pivotal Trial • Source: Shutterstock

More from Anticancer

More from Therapy Areas